The Journal of Korean Academy of Prosthodontics (대한치과보철학회지)

The Korean Academy of Prosthodonitics (대한치과보철학회)
권호 표지
DOI QR코드

DOI QR Code

Combined effects of rhBMP-2 and rhVEGF coated onto implants on osseointegration: pilot study

양극산화 임플란트 표면에 적용된 골형성단백질과 혈관내피세포성장인자가 골유착에 미치는 영향: 예비연구

  • Huh, Jung-Bo (Department of Prosthodontics, School of Dentistry, Pusan National University) ;
  • Yun, Mi-Jung (Department of Prosthodontics, School of Dentistry, Pusan National University) ;
  • Jeong, Chang-Mo (Department of Prosthodontics, School of Dentistry, Pusan National University) ;
  • Shin, Sang-Wan (Department of Prosthodontics, Institute for Clinical Dental Research, Korea University Guro Hospital) ;
  • Jeon, Young-Chan (Department of Prosthodontics, School of Dentistry, Pusan National University)
  • 허중보 (부산대학교 치의학전문대학원 치과보철학교실) ;
  • 윤미정 (부산대학교 치의학전문대학원 치과보철학교실) ;
  • 정창모 (부산대학교 치의학전문대학원 치과보철학교실) ;
  • 신상완 (고려대학교 구로병원 임상치의학연구소 치과보철과) ;
  • 전영찬 (부산대학교 치의학전문대학원 치과보철학교실)
  • Received : 2013.03.08
  • Accepted : 2013.04.04
  • Published : 2013.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The present study is aimed to evaluate the combined effect of recombinant human bone morphogenetic protein 2 (rhBMP-2) and recombinant human vascular endothelial growth factor (rhVEGF) coated onto anodized implants on osseointeration. Materials and methods: Six New Zealand white rabbit were used in this study. Each animal received 4 implants that were either coated with rhBMP-2 and rhVEGF (Study group) or anodized implant (Control group) in both tibia. This was performed using a randomized split-mouth design. A total 24 implants were used. The implant stability quotient (ISQ) value using resonance frequency analyser and removal torque (RTQ) measurement were investigated at 2 and 8 weeks. The t-test was used for statistical analysis (${\alpha}$=.05). Results: Control and study group showed good osseointegration at 8 weeks. The ISQ and RTQ values of study group were significant compared with the control group at 8 weeks (P<.05). However, No statistical significance was observed at 2 weeks (P>.05). Conclusion: It was concluded that rhBMP-2 with rhVEGF coated onto anodized implants can induce better osseointegration at late healing period.

연구 목적: 본 연구는 양극산화 임플란트에 골형성단백질과 혈관내피세포성장인자를 코팅한 임플란트를 토끼의 경골에 식립하여 골과 임플란트 계면의 골유착 향상의 가능성을 평가하고자 시행하였다. 연구 재료 및 방법: 6마리의 토끼 양측 경골에 코팅을 하지 않은 양극 산화 임플란트(대조군)와 골형성단백질과 혈관내피세포성장인자를 코팅한 임플란트(실험군)을 각각 한쪽에 2개씩 식립하였다, 토끼는 2주, 8주에 각각 3마리씩 희생하였고 전체 식립된 임플란트는 24개이었다. 각 시기별, 그룹별 임플란트 수는 각각 6개씩이었다. 임플란트안정지수(resonance frequency analysis (RFA)), 회전 제거력(Removable torque measurement (RTQ))을 희생 시기에 측정하였다. 독립표본 t-test (SPSS Ver. 15.0, Chicago, USA)을 이용하여 2주, 8주에서 대조군과 실험군의 차이를 비교 분석하고, 유의수준95%에서 통계적으로 검정하였다. 결과:대조군과 실험군 모두 8주에서 우수한 골유착을 보였다. 특히 실험군에서 8주에 ISQ, RTQ 값 모두 대조군과 비교하여 우수한 값을 나타내었다 (P<.05). 하지만 2주에서는 두군 사이에 통계적 유의성을 보이지 않았다(P>.05). 결론: 골형성 단백질과 혈관내피세포성장인자를 임플란트 표면에 코팅하여 식립하는 것은 치유의 후반기에 골유착을 증대하는 것으로 사료된다.

Keywords

References

  1. Retzepi M, Lewis MP, Donos N. Effect of diabetes and metabolic control on de novo bone formation following guided bone regeneration. Clin Oral Implants Res 2010;21:71-79. https://doi.org/10.1111/j.1600-0501.2009.01805.x
  2. Sykaras N, Woody RD, Lacopino AM, Triplett RG, Nunn ME. Osseointegration of dental implants complexed with rhBMP-2: a comparative histomorphometric and radiographic evaluation. Int J Oral Maxillofac Implants 2004;19:667-678.
  3. Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 2004;22:58-65. https://doi.org/10.1016/S0736-0266(03)00127-X
  4. Becker J, Kirsch A, Schwarz F, Chatzinikolaidou M, Rothamel D, Lekovic V, Laub M, Jennissen HP. Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs. Clin Oral Investig 2006:10;217-224. https://doi.org/10.1007/s00784-006-0049-0
  5. Huh JB, Ryu JJ, Kim JE, Kim DW, Kim SJ, Park YB, Kim YS, Lee SY, Lee JY, Shin SW. Effects of anodized implants coated with Escherichia coli-derived recombinant Human bone morphogenetic protein-2 on osseointegration in rabbits. Tissue Eng Regen Med 2011;8:62-68.
  6. Huh JB, Kim SE, Kim HE, Kang SS, Choi KH, Jeong CM, Lee JY, Shin SW. Effects of anodized implants coated with Escherichia coli-derived rhBMP-2 in beagle dogs. Int J Oral Maxillofac Surg 2012;41:1577-1584. https://doi.org/10.1016/j.ijom.2012.04.005
  7. Huh JB, Park CK, Kim SE, Shim KM, Choi KH, Kim SJ, Shim JS, Shin SW. Alveolar ridge augmentation using an-odized implants coated with Escherichia coli-derived recombinant human bone morphogenetic protein 2. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:42-49. https://doi.org/10.1016/j.tripleo.2010.09.063
  8. Stenport VF, Johansson C, Heo SJ, Aspenberg P, Albrektsson T. Titanium implants and BMP-7 in bone: an experimental model in the rabbit. J Mater Sci Mater Med 2003;14:247-254.
  9. Schliephake H, Aref A, Scharnweber D, Bierbaum S, Roessler S, Sewing A. Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation. Clin Oral Implants Res 2005;16:563-569. https://doi.org/10.1111/j.1600-0501.2005.01143.x
  10. Park J, Lutz R, Felszeghy E, Wiltfang J, Nkenke E, Neukam FW, Schlegel KA. The effect on bone regeneration of a liposomal vector to deliver BMP-2 gene to bone grafts in peri-implant bone defects. Biomaterials 2007;28:2772-2782. https://doi.org/10.1016/j.biomaterials.2007.02.009
  11. Stadlinger B, Pilling E, Huhle M, Mai R, Bierbaum S, Scharnweber D, Kuhlisch E, Loukota R, Eckelt U. Evaluation of osseointegration of dental implants coated with collagen, chondroitin sulphate and BMP-4: an animal study. Int J Oral Maxillofac Surg 2008;37:54-59 https://doi.org/10.1016/j.ijom.2007.05.024
  12. Kim SE, Yun YP, Lee JY, Shim JS, Park K, Huh JB. Co-delivery of platelet-derived growth factor (PDGF-BB) and bone morphogenic protein (BMP-2) coated onto heparinized titanium for improving osteoblast function and osteointegration. J Tissue Eng Regen Med 2013 Jan 3.
  13. Huh JB, Lee JY, Lee KL, Kim SE, Yun MJ, Shim JS, Shim JS, Shin SW. Effects of the immobilization of heparin and rhPDGFBB to titanium surfaces for the enhancement of osteoblastic functions and anti-inflammation. J Adv Prosthodont 2011;3:152-160. https://doi.org/10.4047/jap.2011.3.3.152
  14. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-676. https://doi.org/10.1038/nm0603-669
  15. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993;12:303-324. https://doi.org/10.1007/BF00665960
  16. Zelzer E, Olsen BR. Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol 2005;65:169-187.
  17. Harper J, Klagsbrun M. Cartilage to bone-angiogenesis leads the way. Nat Med 1999;5:617-618. https://doi.org/10.1038/9460
  18. Rabie AB, Shum L, Chayanupatkul A. VEGF and bone formation in the glenoid fossa during forward mandibular positioning. Am J Orthod Dentofacial Orthop 2002;122:202-209. https://doi.org/10.1067/mod.2002.125991
  19. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000;141:1667-1674. https://doi.org/10.1210/endo.141.5.7458
  20. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002;110:751-759. https://doi.org/10.1172/JCI15153
  21. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008;43:931-940. https://doi.org/10.1016/j.bone.2008.06.019
  22. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005;9:777-794. https://doi.org/10.1111/j.1582-4934.2005.tb00379.x
  23. Wang DS, Miura M, Demura H, Sato K. Anabolic effects of 1,25- dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 1997;138:2953-2962. https://doi.org/10.1210/endo.138.7.5275
  24. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002;30:472-477. https://doi.org/10.1016/S8756-3282(01)00690-1
  25. Hall J, Sorensen RG, Wozney JM, Wikesjo UM. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J Clin Periodontol 2007;34:444-451. https://doi.org/10.1111/j.1600-051X.2007.01064.x
  26. Wikesjo UM, Qahash M, Polimeni G, Susin C, Shanaman RH, Rohrer MD, Wozney JM, Hall J. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations. J Clin Periodontol 2008;35:1001-1010. https://doi.org/10.1111/j.1600-051X.2008.01321.x
  27. Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 2008;108:18-31. https://doi.org/10.1254/jphs.08036FP
  28. Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 2005;20:848-857.
  29. Kanczler JM, Ginty PJ, White L, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 2010;31:1242-1250. https://doi.org/10.1016/j.biomaterials.2009.10.059
  30. Li G, Corsi-Payne K, Zheng B, Usas A, Peng H, Huard J. The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A 2009;15:2123-2133 https://doi.org/10.1089/ten.tea.2008.0214
  31. Ramazanoglu M, Lutz R, Ergun C, von Wilmowsky C, Nkenke E, Schlegel KA. The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium- phosphate-coated implants on osseointegration. Clin Oral Implants Res 2011;22:1433-1439. https://doi.org/10.1111/j.1600-0501.2010.02133.x
  32. Buser D, Broggini N, Wieland M, Schenk RK, Denzer AJ, Cochran DL, Hoffmann B, Lussi A, Steinemann SG. Enhanced bone apposition to a chemically modified SLA titanium surface. J Dent Res 2004;83:529-533. https://doi.org/10.1177/154405910408300704
  33. Le Guehennec L, Goyenvalle E, Lopez-Heredia MA, Weiss P, Amouriq Y, Layrolle P. Histomorphometric analysis of the osseointegration of four different implant surfaces in the femoral epiphyses of rabbits. Clin Oral Implants Res 2008;19:1103-1110 https://doi.org/10.1111/j.1600-0501.2008.01547.x
  34. Stadlinger B, Pilling E, Huhle M, Mai R, Bierbaum S, Bernhardt R, Scharnweber D, Kuhlisch E, Hempel U, Eckelt U. Influence of extracellular matrix coatings on implant stability and osseointegration: an animal study. J Biomed Mater Res B Appl Biomater 2007;83:222-231.
  35. Lioubavina-Hack N, Lang NP, Karring T. Significance of primary stability for osseointegration of dental implants. Clin Oral Implants Res 2006;17:244-250. https://doi.org/10.1111/j.1600-0501.2005.01201.x
  36. Liu Y, de Groot K, Hunziker EB. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 2005;36:745-757. https://doi.org/10.1016/j.bone.2005.02.005
  37. Luo T, Zhang W, Shi B, Cheng X, Zhang Y. Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery. Clin Oral Implants Res 2012;23:467-473. https://doi.org/10.1111/j.1600-0501.2011.02164.x
  38. Schmid J, Wallkamm B, Hammerle CH, Gogolewski S, Lang NP. The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment. Clin Oral Implants Res 1997;8:244-248. https://doi.org/10.1034/j.1600-0501.1997.080311.x
  39. Sojo K, Sawaki Y, Hattori H, Mizutani H, Ueda M. Immunohistochemical study of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2, -4 (BMP-2, -4) on lengthened rat femurs. J Craniomaxillofac Surg 2005;33: 238-245. https://doi.org/10.1016/j.jcms.2005.02.004

Cited by

  1. Effect of immobilization of the recombinant human bone morphogenetic protein 2 (rhBMP-2) on anodized implants coated with heparin for improving alveolar ridge augmentation in beagle dogs: Radiographic observations vol.51, pp.4, 2013, https://doi.org/10.4047/jkap.2013.51.4.307